Pharmaceutical Composition For Dermal Use To Treat Psoriasis, Sebopsoriasis Or Seborrhoic Dermatitis Comprising A Vitamin D And A Corticosteroid

Patent No. EP2450043 (titled "Pharmaceutical Composition For Dermal Use To Treat Psoriasis, Sebopsoriasis Or Seborrhoic Dermatitis Comprising A Vitamin D And A Corticosteroid") was filed by LEO Pharma on Jan 27, 2000. The application was issued on Aug 17, 2016.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
HEXALMay 17, 2017GREINER

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2450043

LEO PHARMA
Application Number
EP11196069A
Filing Date
Jan 27, 2000
Status
Revoked
Oct 1, 2021
Publication Date
Aug 17, 2016